Aethlon Medical Inc.

AEMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.32

+$0.01 (+0.16%)

At close: Sep 21, 2026, 4:00 PM ET

$6.22

-$0.10 (-1.59%)

Pre-market: Sep 22, 2026, 6:20 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.32M

Enterprise Value $-1.24M

Beta 1.40

Average Volume 814.58K

Shares Outstanding (Diluted) 384.71K

Shares Change YoY 85.27%

Institutional Ownership 2.10%

Exchange NASDAQ

ISIN US00808Y7031

Price Performance

Price Change 1M 126.5%

Price Change 3M -7.1%

Price Change 6M -45.5%

Price Change YTD -55.2%

Price Change 1Y -83.8%

Price Change 3Y -99.3%

Price Change 5Y -100.0%

1M CAGR (ann.) 108.9%

1Y CAGR (ann.) -83.3%

5Y CAGR (ann.) -78.7%

All-Time CAGR -44.3%

Valuation

PE Ratio -0.54

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.64

P/FCF Ratio -0.00

P/Adj. FCF Ratio -0.00

P/OCF Ratio -0.00

EV/Sales N/A

EV/EBIT 0.18

EV/EBITDA 0.19

EV/FCF 0.00

Earnings Yield -185.1%

FCF Yield -57407.0%

Adj. FCF Yield -58915.2%

Financial Health

Net Cash $4.82M

Total Debt $367.61K

Cash & Short-Term Investments $4.93M

Total Assets $6.24M

Current Ratio 5.42

Quick Ratio 5.42

Debt / Equity Ratio 0.07

Debt / EBITDA -0.06

Debt / FCF -0.00

OCF / Debt -5,173.51

Interest Coverage -492.66

Altman Z-Score -40.55

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -2.6%

Returns

Return on Assets -111.3%

Return on Equity -123.1%

Return on Invested Capital -127.2%

Return on Capital Employed -136.2%

Return on Tangible Assets -111.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -61.0%

Revenue CAGR 10Y -14.2%

EPS CAGR 3Y 114.5%

EPS CAGR 5Y 53.5%

EPS CAGR 10Y -6.7%

FCF CAGR 3Y -147.9%

FCF CAGR 5Y -97.3%

FCF CAGR 10Y -52.9%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 3

EPS Growth Next 3Y 31.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$2.91

EPS Growth Est (next Q) -84.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $1.50

Price Target Upside -76.3%

Cash Flow

Operating Cash Flow $-1.9B

Free Cash Flow $-1.91B

Adj. Free Cash Flow $-1.96B

FCF Per Share -$4,967.38

OCF Per Share -$4,943.59

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-388.01K

Operating Income $-7.08M

EBITDA $-6.52M

Net Income $-6.94M

EPS (Diluted) -$11.70

Revenue / Employee N/A

Profit / Employee $-770.84K

Employees 9